The impact of the COVID-19 pandemic on symptomatic breast cancer presentations in an Irish breast cancer unit: a retrospective cohort study
Irish Journal of Medical Science (1971 -) · 2024
DOI: 10.1007/s11845-024-03688-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024. Verfasst von Áine Higgins und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Cork University Hospital and University College Cork, Cork, Ireland. ainehiggins1999@gmail.com. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College Cork.
Abstract (Originalsprache)
Background
The coronavirus-19 (COVID-19) pandemic caused delays in the diagnosis and management of breast cancer which may have affected disease presentation. The aim of this study was to compare rates of metastatic disease, tumour characteristics and management in breast cancer patients diagnosed before and after the onset of COVID-19.
Methods
A retrospective chart review was conducted on patients in a university teaching hospital who were diagnosed with invasive symptomatic breast cancer in 2019 (prepandemic control group) and in 2020, 2021, and 2022 (pandemic study groups). Rates of new metastatic presentations, tumour histopathological characteristics, operation type, and therapies administered were statistically compared.
Results
A total of 1416 patients were identified. There was a significant increase in new metastatic breast cancer presentations in 2022 compared to 2019 (14.0% vs 3.8%, p ≤ 0.001), with non-significant increases in 2020 and 2021. Rates of adjuvant radiotherapy increased in 2020 and decreased in 2022 compared to 2019, with no significant change in neoadjuvant or adjuvant chemotherapy rates. Rates of axillary surgery increased during 2020 and 2021. There was an increase in high-grade tumours and lymphovascular invasion (LVI), and less frequent oestrogen receptor (ER) positivity in pandemic groups. No significant change was noted in BCS to mastectomy ratios, overall nodal positivity rates, or median tumour size.
Conclusion
Symptomatic breast cancers diagnosed since the onset of COVID-19 demonstrated an increase in new metastatic presentations and more aggressive histopathological characteristics when compared to a pre-pandemic control group. Rates of adjuvant radiotherapy and axillary surgery increased during the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Cork University Hospital and University College Cork, Cork, Ireland. ainehiggins1999@gmail.com.
- Department of Medical Oncology, College of Medicine and Health, Cork University Hospital and Cancer Research@UCC, University College Cork, Cork, Ireland.
- Department of Breast Surgery, College of Medicine and Health, Cork University Hospital and Cancer Research@UCC, University College Cork, Cork, Ireland.
Förderung
- University College Cork
Zitieren
APA
Higgins, Á., O'Reilly, S., & O'Sullivan, M. J. (2024). The impact of the COVID-19 pandemic on symptomatic breast cancer presentations in an Irish breast cancer unit: a retrospective cohort study. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-024-03688-4
Vancouver
Higgins Á, O'Reilly S, O'Sullivan MJ. The impact of the COVID-19 pandemic on symptomatic breast cancer presentations in an Irish breast cancer unit: a retrospective cohort study. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-024-03688-4
BibTeX
@article{Higgins2024,
author = {Higgins, Áine and O'Reilly, Seamus and O'Sullivan, Martin J},
title = {The impact of the COVID-19 pandemic on symptomatic breast cancer presentations in an Irish breast cancer unit: a retrospective cohort study},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2024},
doi = {10.1007/s11845-024-03688-4}
}
EUVIMED